Skip to main content
. 2023 Jan 29;13(3):540. doi: 10.3390/nano13030540

Figure 3.

Figure 3

Prescription screening for protein canopy. The concentration of BSA was changed while keeping other factors fixed. The particle size (a), potential (b), and particle size and PDI stability (c) were investigated. The optimal concentration of BSA was adopted, and while other factors were unchanged, the volume ratio of protein solution to cationic liposome solution was changed. The particle size (d), potential (e), and particle size and PDI stability (f) were investigated.